Indications
Therapeutic Asset Ratings
5,098 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Lenalidomide
B-Cell Chronic Lymphocytic Leukemia
Vitebsk Regional Clinical Cancer Centre
P3
B
(62)
Lenvatinib
Colorectal Cancer
Seoul National University Bundang Hospital
P3
B
(62)
Loperamide
Diarrheal Disease
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
P3
B
(62)
Luspatercept
Beta Thalassemia
Bristol-Myers Squibb
P3
B
(62)
Methotrexate
Acute Myeloid Leukemia
Children's Oncology Group
P3
B
(62)
Methotrexate
Graft Versus Host Disease
University of Michigan Rogel Cancer Center
P3
B
(62)
Methotrexate
Myelodysplastic Syndrome
The First Affiliated Hospital of Soochow University
P3
B
(62)
Nal Er
Idiopathic Pulmonary Fibrosis
Trevi Therapeutics
P3
B
(62)
nd0612
Parkinson Disease
NeuroDerm Ltd.
P3
B
(62)
Nivestim
Chronic Myeloid Leukemia
City of Hope Medical Center
P3
B
(62)
Nivestim
Myeloproliferative Neoplasm
City of Hope Medical Center
P3
B
(62)
Nivestim
Smoldering Plasma Cell Myeloma
Regeneron Pharmaceuticals
P3
B
(62)
Olaparib
Fallopian Tube Clear Cell Adenocarcinoma
National Cancer Institute (NCI)
P3
B
(62)
Olaparib
Fallopian Tube Transitional Cell Carcinoma
National Cancer Institute (NCI)
P3
B
(62)
Olaparib
Fallopian Tube Carcinoma
National Cancer Institute (NCI)
P3
B
(62)
Orca-T
Mixed Phenotype Acute Leukemia
Orca Biosystems, Inc.
P3
B
(62)
Orforglipron
Type 2 Diabetes Mellitus
Eli Lilly and Company
P3
B
(62)
Oritinib
Non-Small Cell Lung Carcinoma
Nanjing Sanhome Pharmaceutical, Co., Ltd.
P3
B
(62)
Oxygen
Traumatic Brain Injury
University of South Florida
P3
B
(62)
Pegfilgrastim
Hodgkins Lymphoma
Michael Spinner, MD
P3
B
(62)
Pralatrexate
Angioimmunoblastic T-Cell Lymphoma
Corvus Pharmaceuticals, Inc.
P3
B
(62)
Regorafenib
Hepatocellular Carcinoma
University of Miami
P3
B
(62)
Rivoceranib
Neoplasm
Beidahuang Industry Group General Hospital
P3
B
(62)
Romidepsin
Childhood Acute Myeloid Leukemia
Washington University School of Medicine
P3
B
(62)
Sorafenib
Acute Myeloid Leukemia, FLT3 Internal Tandem Duplication
The First Affiliated Hospital of Soochow University
P3
B
(62)
Showing 2476 to 2500 of 5,098 assets
Previous
Page 100 of 204
Next